Use of Retinalamin at an Early Stage of Treatment of Non-proliferative Diabetic Retinopathy in Children with Type 1 Diabetes Mellitus
The aim of the work is to study the effect of retinalamin on circulatory dynamics and functional state of the retina when treating non-proliferative diabetic retinopathy in children with insulin dependent diabetes mellitus.
Materials and Methods. There were included into the study 100 children with signs of diabetic retinopathy: microhemorrhages, capillary network distention. All the patients received standard treatment of type 1 diabetes mellitus: insulin therapy, lipoic acid medications, antioxidants.
Conclusion. Retinalamin administration at an early stage of non-proliferative diabetic retinopathy reduces the risk of progression of the complication. According to Doppler sonography of ophthalmic artery, retinalamin has a favourable effect on capillary wall of ophthalmic artery and improves flow properties of blood on the local level. The course of injections of the medication in young children can be halved that is less traumatic and more cost effective.
